Doctor Joakim Bo Kunkel

Doctor Joakim Bo Kunkel

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

Member of:

MD, Ph.D.-fellow. Research interests: Cardiogenic shock, inflammation and imaging. Critical thinking about digital health technology.

Presentations Articles

ORBI risk score and inflammatory response in patients with acute ST-elevation myocardial infarction

Event: ESC Congress 2024

Topic: Inflammation

Session: Advancements in cardiovascular therapies for ST-elevation myocardial infarction: from molecular insights to clinical applications

Access

Cardiogenic shock due to acute right ventricular failure in ST-elevation myocardial infarction

Event: ESC Acute CardioVascular Care 2024

Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care

Session: Mastering acute cardiac care in the real world: challenging cases and clinical dilemmas I

Access

Psychotropic medication use and mortality in patients with acute myocardial infarction complicated by cardiogenic shock

Event: ESC Acute CardioVascular Care 2024

Topic: Cardiogenic Shock

Session: Cardiogenic shock: epidemiology and prognostication

Access

Myocardial salvage and infarct characteristics in patients with ST-elevation myocardial infarction classified by ORBI risk score

Event: ESC Congress 2023

Topic: ST-Elevation Myocardial Infarction (STEMI)

Session: Risk stratification in acute coronary syndromes (2)

Access

Sex differences in acute hemodynamic response in comatose survivors of OHCA

Event: ESC Acute CardioVascular Care 2023

Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care

Session: Epidemiological aspects and hemodynamics in cardiac arrest

Access

Low-dose dobutamine infusion and single-dose tocilizumab in acute myocardial infarction patients with high risk of cardiogenic shock development - rationale and design of the DOBERMANN trial

Event: ESC Acute CardioVascular Care 2023

Topic: Cardiogenic Shock

Session: Acute coronary syndromes, cardiogenic shock and acute kidney injury

Access

Association between inflammatory biomarkers and 30-day mortality in patients with acute myocardial infarction complicated by cardiogenic shock.

Event: ESC Acute CardioVascular Care 2022

Topic: Acute Coronary Syndromes

Session: Best ePoster in Acute Coronary Syndromes – Biomarkers and inflammation

Access

Single coronary artery in a 76-year old woman with ST-elevation myocardial infarction.

Event: ESC Acute CardioVascular Care 2022

Topic: Interventional Cardiology

Session: Clinical case session

Access

Association between inflammatory biomarkers and 30-day mortality in patients with acute myocardial infarction complicated by cardiogenic shock

Event: ESC Acute CardioVascular Care 2022

Topic: Shock

Session: e-Posters session

Access

Inflammation and neurohormonal activation is increased at hospital admission in patients with ST-elevation myocardial infarction with diabetes compared to non-diabetic patients.

Event: ACVC 2021

Topic: ST-Elevation Myocardial Infarction (STEMI)

Session: Young Investigators Award session

Access

ESC 365 is supported by

Explore sponsored resources

Doctor Joakim Bo Kunkel

Biography

Contributor content

ORBI risk score and inflammatory response in patients with acute ST-elevation myocardial infarction

Cardiogenic shock due to acute right ventricular failure in ST-elevation myocardial infarction

Psychotropic medication use and mortality in patients with acute myocardial infarction complicated by cardiogenic shock

Myocardial salvage and infarct characteristics in patients with ST-elevation myocardial infarction classified by ORBI risk score

Sex differences in acute hemodynamic response in comatose survivors of OHCA

Low-dose dobutamine infusion and single-dose tocilizumab in acute myocardial infarction patients with high risk of cardiogenic shock development - rationale and design of the DOBERMANN trial

Association between inflammatory biomarkers and 30-day mortality in patients with acute myocardial infarction complicated by cardiogenic shock.

Single coronary artery in a 76-year old woman with ST-elevation myocardial infarction.

Association between inflammatory biomarkers and 30-day mortality in patients with acute myocardial infarction complicated by cardiogenic shock

Inflammation and neurohormonal activation is increased at hospital admission in patients with ST-elevation myocardial infarction with diabetes compared to non-diabetic patients.

ESC 365 is supported by

Doctor Joakim Bo Kunkel Follow

Biography

Contributor content

ORBI risk score and inflammatory response in patients with acute ST-elevation myocardial infarction

Cardiogenic shock due to acute right ventricular failure in ST-elevation myocardial infarction

Psychotropic medication use and mortality in patients with acute myocardial infarction complicated by cardiogenic shock

Myocardial salvage and infarct characteristics in patients with ST-elevation myocardial infarction classified by ORBI risk score

Sex differences in acute hemodynamic response in comatose survivors of OHCA

Low-dose dobutamine infusion and single-dose tocilizumab in acute myocardial infarction patients with high risk of cardiogenic shock development - rationale and design of the DOBERMANN trial

Association between inflammatory biomarkers and 30-day mortality in patients with acute myocardial infarction complicated by cardiogenic shock.

Single coronary artery in a 76-year old woman with ST-elevation myocardial infarction.

Association between inflammatory biomarkers and 30-day mortality in patients with acute myocardial infarction complicated by cardiogenic shock

Inflammation and neurohormonal activation is increased at hospital admission in patients with ST-elevation myocardial infarction with diabetes compared to non-diabetic patients.

ESC 365 is supported by

Doctor Joakim Bo Kunkel